Now showing items 1-3 of 3
Loss to follow-up barriers in care for Cornea Ulcers and Glaucoma: A Scoping Review Protocol
(2021-07-09)
In this scoping review, we sought to understand the barriers, both financial and nonfinancial, to accessing care for treatment of glaucoma and corneal ulcers utilizing Penchansky and Thomas’ five dimensions associated with ...
Teprotumumab divergently alters fibrocyte gene expression: Implications for thyroid-associated ophthalmopathy
(Ox ford University Press, 2022-05-23)
Context: Teprotumumab, an IGF-I receptor inhibitor (IGF-IR), is effective in thyroid-associated ophthalmopathy (TAO). The drug can modulate induction by TSH of IL-6 and IL-8 in CD34+ fibrocytes and their putative derivatives, ...